MODIFY Study — Type 2 Diabetes
- November 17, 2022
In April 2019, we launched our first multi-organ imaging study in patients with metabolic diseases, Multi Organ Assessment in Patients with Type 2 Diabetes, known as MODIFY.
We wanted to better understand diabetes and find out how to accurately diagnose related diseases. The study used imaging to assess the health of multiple organs in the body including the liver, kidneys, pancreas, and spleen in people with type 2 diabetes.
On the 9th November 2022 we presented the results of this study in our first public webinar on type 2 diabetes.
You can watch the recording of this webinar on YouTube by clicking here.